Collaborative Science

Accelerating time to market and driving innovation with collaboration, knowledge based under-standing and prediction.

MDDR

MDDR contains over 150,000 biologically relevant compounds and well-defined derivatives. Updates add about 10,000 substances a year to the database. MDDR, jointly produced by BIOVIA and Thomson Reuters, covers patent literature, journals, meetings, and congresses.

Medicinal chemists, pharmacologists, and molecular modelers use the database to create SAR tables (matching chemical structure to pharmacological effect) and find competitive information about compounds similar to their lead compounds.

MDDR provides:

  • Chemical structure
  • Calculated properties based on chemical structure
  • 3D models (calculated with Corina)
  • Compound name – trademarks and company codes
  • CAS registry number
  • Biological activity based on the Prous classification system
  • Description of therapeutic action containing ED50, LD50, inhibition values, etc.
  • Patent information including patent number, title, source, priority number and inventors’ names
  • Literature references hyperlinked to primary literature (full text, abstracts, patents, conference proceedings, etc.)
  • Company codes, generic names, trade names and trademark names
  • Originating company
  • Development phase in the R&D process

Browse By: